Drug ID: | NPD3531 |
Drug Name: | Esreboxetine |
Molecular Formula: | C19H23NO3 |
Canonical SMILES: | CCOc1ccccc1O[C@@H](c1ccccc1)[C@H]1OCCNC1 |
Standard InCHI: | InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1 |
Standard InCHIKey: | CBQGYUDMJHNJBX-OALUTQOASA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL000526; DAP000720 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | 4808 |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 65856 |
ChEBI | |
CAS Number |
Molecular Weight | 313.17 |
ALogP | -0.596 |
MLogP | 3.11 |
XLogP | 4.527 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 7 |
TPSA | 39.72 |
RO5 Violation | 0 |